Ethyl acrylate
Ethyl acrylate releases at Arkema INC Clear Lake rose from 7k lb to 384k lb (52.9×) between 2023 and 2024.
Total reported releases 822k lb rose by an order of magnitude year over year (+939%). Total releases concentrations have more than doubled since 2011.
9502 B BAYPORT BLVD, Pasadena, Texas · 325110 · Chemicals · operated by Arkema Delaware INC
Ethyl acrylate releases at Arkema INC Clear Lake rose from 7k lb to 384k lb (52.9×) between 2023 and 2024.
Acrylic acid releases at Arkema INC Clear Lake rose from 17k lb to 302k lb (17.6×) between 2023 and 2024.
Butyl acrylate releases at Arkema INC Clear Lake rose from 12k lb to 44k lb (3.5×) between 2023 and 2024.
Ethyl acrylate volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
Acrylic acid concentrations have more than doubled since 2022.
n-Butyl alcohol volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
Butyl acrylate concentrations have more than doubled since 2010.
Ammonia concentrations are up 18% since 2010.
Methyl acrylate concentrations have more than doubled since 2015.
Ethylene glycol concentrations are up 13% since 2010.
Propylene concentrations have fallen 20% since 2010.
Within 3 miles of this facility (14 Census block groups, population-weighted demographics): a population of 24,652. Why we surface this →
Low-income
People of color
Under age 5
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.